Edition:
United States

Medifast Inc (MED)

MED on New York Consolidated

38.64USD
2 Dec 2016
Change (% chg)

$-0.17 (-0.44%)
Prev Close
$38.81
Open
$38.65
Day's High
$39.40
Day's Low
$38.53
Volume
64,678
Avg. Vol
91,415
52-wk High
$42.14
52-wk Low
$27.12

Latest Key Developments (Source: Significant Developments)

Medifast announces appointment of Daniel Chard as CEO
Monday, 3 Oct 2016 05:05pm EDT 

Medifast Inc : Chard succeeds michael macdonald, who will stay with medifast in role of executive chairman of board . Chard has been appointed as a member of medifast's board of directors, effective today, bringing size of board to 10 members . Medifast, inc. Announces appointment of direct selling industry veteran daniel r. Chard as chief executive officer . Says expects to meet or exceed q3 guidance for revenue from continuing operations in range of approximately $64.0 million to $67.0 million .Expects to meet or exceed q3 guidance for earnings per diluted share from continuing operations in range of $0.43 to $0.46 per diluted share.  Full Article

Medifast raises FY adjusted earnings from cont ops forecast
Wednesday, 3 Aug 2016 04:05pm EDT 

Medifast Inc : Medifast, inc. Announces second quarter 2016 financial results . Q2 adjusted earnings per share $0.63 from continuing operations . Sees q3 2016 revenue about $64 million to $67 million . Q2 revenue $71.1 million . Sees q3 2016 earnings per share $0.43 to $0.46 from continuing operations . Q2 earnings per share $0.29 from continuing operations . Sees fy 2016 revenue $275 million to $282 million . Says company reiterated its fy guidance for revenue from continuing operations . Says is raising its fy guidance for adjusted earnings per diluted share from continuing operations to $1.79 to $1.84 . Fy 2016 earnings per diluted share from continuing operations is now expected to be in range of $1.38 to $1.43 . Says company expects q3 2016 revenue from continuing operations to be in range of approximately $64.0 million to $67.0 million .Says fy earnings per diluted share from continuing operations is now expected to be in range of $1.38 to $1.43.  Full Article

Medifast Inc Raises FY 2016 guidance; gives Q2 2016 guidance
Wednesday, 4 May 2016 04:05pm EDT 

Medifast Inc:Expects Q2 2016 net revenue from continuing operations to be in the range of approximately $70.0 million to $73.0 million and adjusted earnings per diluted share from continuing operations in the range of $0.50 to $0.53 per diluted share.Raised FY 2016 guidance for revenue from continuing operations to be in the range of $275.0 million to $282.0 million and adjusted earnings per diluted share from continuing operations in the range of $1.75 to $1.80 per diluted share.  Full Article

Medifast Inc announces initiation of quarterly dividend
Wednesday, 16 Dec 2015 04:15pm EST 

Medifast Inc:Board of Directors has authorized a dividend program under which it intends to pay a regular quarterly cash dividend to its stockholders.Initial quarterly cash dividend of $0.25 per share is payable on February 10, 2016 to stockholders of record as of the close of business on December 28.  Full Article

Medifast Inc narrows FY 2015 guidance; gives Q4 2015 guidance below analysts' estimates
Thursday, 5 Nov 2015 04:05pm EST 

Medifast Inc:Expects Q4 2015 net revenue from continuing operations to be in the range of approximately $60.5 to $63.5 million and earnings per diluted share from continuing operations in the range of $0.31 to $0.35 per diluted share.Expects FY 2015 revenue from continuing operations to be in the range of $272.0 to $275.0 million and earnings per diluted share from continuing operations in the range of $1.72 to $1.76 per diluted share.Q4 2015 revenue of $63.8 million and EPS of $0.41 - Thomson Reuters I/B/E/S.FY 2015 revenue of $276 million and EPS of $1.67 - Thomson Reuters I/B/E/S.  Full Article

Medifast Inc gives Q3 2015 guidance below analysts' estimates; lowers FY 2015 guidance
Wednesday, 5 Aug 2015 04:05pm EDT 

Medifast Inc:Expects Q3 2015 net revenue from continuing operations to be in the range of about $65.0 to $68.0 million and earnings per diluted share from continuing operations in the range of $0.40 - $0.43 per diluted share.Now Expects FY 2015 revenue from continuing operations to be in the range of $270.0 to $280.0 million and earnings per diluted share from continuing operations in the range of $1.70 to $1.80 per diluted share.Q3 2015 revenue of $71.5 million and EPS of $0.47 - Thomson Reuters I/B/E/S.FY 2015 revenue of $285 million and EPS of $1.80 - Thomson Reuters I/B/E/S.  Full Article

Medifast Inc gives Q2 2015 guidance above analysts' estimates; reiterates FY 2015 guidance
Thursday, 7 May 2015 04:05pm EDT 

Medifast Inc:Expects Q2 2015 net revenue from continuing operations to be in the range of about $72.0 to $74.0 million.Expects Q2 2015 earnings per diluted share from continuing operations in the range of $0.47 to $0.50 per diluted share.Reiterates its previous FY 2015 guidance of revenue from continuing operations to be in the range of $285 to $300 million and earnings per diluted share from continuing operations in the range of $1.85 to $1.95 per diluted share.Q2 2015 revenue of $70.4 million and EPS of $0.46 - Thomson Reuters I/B/E/S.FY 2015 revenue of $277.1 million and EPS of $1.83 - Thomson Reuters I/B/E/S.  Full Article

Medifast Inc gives Q1 2015 guidance below analysts' estimates; gives FY 2015 mixed guidance
Thursday, 12 Mar 2015 04:05pm EDT 

Medifast Inc:Expects Q1 2015 net revenue from continuing operations to be in the range of about $70.0 to $73.0 million and earnings per diluted share from continuing operations in the range of $0.33 to $0.35 per diluted share.Expects FY 2015 revenue from continuing operations to be in the range of $285 to $300 million and earnings per diluted share from continuing operations in the range of $1.85 to $1.95 per diluted share.Q1 2015 revenue of $84 million and EPS of $0.43 - Thomson Reuters I/B/E/S.FY 2015 revenue of $308 million and EPS of $1.83 - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Medifast announces third quarter 2016 financial results

* Medifast, Inc. announces third quarter 2016 financial results